Abeona Therapeutics Inc. Rings Closing Bell at Nasdaq on World Rare Disease Day
March 1, 2017
Congratulations to our friends at Abeona Therapeutics Inc. (ABEO), a leading clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, who were invited to visit the Nasdaq MarketSite in Times Square to raise awareness for Rare Disease Day this year.
In honor of the occasion, Timothy J. Miller, Ph.D., President and Chief Executive Officer, rang the Closing Bell.
Sign up for updates straight to your inbox.